| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |